kabutan

StemCell Institute(7096) Summary

7096
TSE Growth
StemCell Institute
776
JPY
+2
(+0.26%)
Dec 5, 12:44 pm JST
5.00
USD
Dec 4, 10:44 pm EST
Result
PTS
outside of trading hours
773.1
Dec 5, 10:43 am JST
Summary Chart Historical News Financial Result
PER
24.4
PBR
3.00
Yield
ー%
Margin Trading Ratio
12.69
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
771 JPY 4.97 USD
Previous Close Dec 4
774 JPY 4.98 USD
High Dec 5, 9:35 am
780 JPY 5.03 USD
Low Dec 5, 9:00 am
771 JPY 4.97 USD
Volume
7,900
Trading Value
6.00M JPY 0.04M USD
VWAP
775.57 JPY 5.0 USD
Minimum Trading Value
77,600 JPY 500 USD
Market Cap
7.95B JPY 0.05B USD
Number of Trades
43
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
201
1-Year High Jul 16, 2025
5,341
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 49,100 351,100 7.15
Nov 21, 2025 39,500 343,600 8.70
Nov 14, 2025 28,300 345,500 12.21
Nov 7, 2025 30,700 319,300 10.40
Oct 31, 2025 33,700 318,800 9.46
Company Profile
StemCell Institute operates a cell bank business for regenerative medicine, focusing on the separation and storage of umbilical cord blood. It is part of the Nihon Trim Group.
Sector
Services
StemCell Institute develops a cell bank business for regenerative medicine and cell therapy. The company separates and stores cells derived from perinatal tissues such as umbilical cord blood and umbilical cords for future medical treatments. Umbilical cord blood contains hematopoietic stem cells and mesenchymal cells, and clinical research is progressing on regenerative medicine and cell therapy for pediatric central nervous system diseases and autism spectrum disorders. StemCell Institute has cell processing centers in Tokyo and Yokohama, and a cell storage center in Yokohama, with various certifications including a license for manufacturing specific cell products. In addition to umbilical cord blood storage, the company has also launched umbilical cord tissue storage services. StemCell Institute is also engaged in the development of regenerative medicine products and business development and investment in related fields.